GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oneness Biotech Co Ltd (LUX:ONEA) » Definitions » Total Liabilities

Oneness Biotech Co (LUX:ONEA) Total Liabilities : $26.37 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Oneness Biotech Co Total Liabilities?

Oneness Biotech Co's Total Liabilities for the quarter that ended in Mar. 2024 was $26.37 Mil.

Oneness Biotech Co's quarterly Total Liabilities declined from Jun. 2023 ($22.83 Mil) to Sep. 2023 ($19.71 Mil) but then increased from Sep. 2023 ($19.71 Mil) to Mar. 2024 ($26.37 Mil).

Oneness Biotech Co's annual Total Liabilities increased from Dec. 2020 ($57.61 Mil) to Dec. 2021 ($59.17 Mil) but then declined from Dec. 2021 ($59.17 Mil) to Dec. 2022 ($22.85 Mil).


Oneness Biotech Co Total Liabilities Historical Data

The historical data trend for Oneness Biotech Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oneness Biotech Co Total Liabilities Chart

Oneness Biotech Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.51 17.22 57.61 59.17 22.85

Oneness Biotech Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.85 22.51 22.83 19.71 26.37

Oneness Biotech Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Oneness Biotech Co's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6.805+(8.159+7.885
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=22.85

Total Liabilities=Total Assets (A: Dec. 2022 )-Total Equity (A: Dec. 2022 )
=508.292-485.443
=22.85

Oneness Biotech Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6.185+(12.225+7.955
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=26.37

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=475.623-449.258
=26.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oneness Biotech Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Oneness Biotech Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Oneness Biotech Co (LUX:ONEA) Business Description

Traded in Other Exchanges
Address
No. 236, Section 4, Xinyi Road, 11th Floor, Daan District, Taipei, TWN, 106
Oneness Biotech Co Ltd is a Taiwan based biopharmaceutical company. The company develops healthcare drugs. Its products are used for chronic diabetic, dengue hemorrhagic fever, and Rheumatoid Arthritis. The company's operating segment includes New Drug Research and Development and Agricultural Products Cultivation. It generates maximum revenue from New Drug Research and Development segment.

Oneness Biotech Co (LUX:ONEA) Headlines

No Headlines